Evidence map›Paper›PMID 38168538›Full record

ArticleScientific reports2024

High-dose benzodiazepine use and QTc interval prolongation, a latent class analysis study.

Lorenzo Zamboni, Igor Portoghese, Rebecca Casari, Francesca Fusina, Laura Santin, Luigi Isaia Lecca, Simone Campagnari, Silvia Carli, Thomas Zandonai, Fabio Lugoboni

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. QTc interval prolongation in ICU patients: risk assessment and predictors.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Lorenzo ZamboniUnit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy. lorenzo.zamboni88@gmail.com.
Igor PortogheseDipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari, Cagliari , Italy.
Rebecca CasariUnit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy.
Francesca FusinaDepartment of General Psychology, University of Padova, Padua, Italy.
Laura SantinUnit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy.
Luigi Isaia LeccaDipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari, Cagliari , Italy.
Simone CampagnariUnit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy.
Silvia CarliUnit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy.
Thomas ZandonaiDepartment of Pharmacology, Paediatrics and Organic Chemistry, Miguel Hernández University of Elche, Elche, Spain.
Fabio LugoboniUnit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy.
University of Verona · ITUniversity of Cagliari · ITUniversity of Padua · ITUniversity of Trento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzodiazepine (BDZ) addiction is a widespread and multifaceted phenomenon. For many patients, especially females, the concomitant use of other drugs also increases their risk of QTc prolongation, possibly leading to complications such as seizures and even sudden death. However, the relationship between BDZ use and QTc prolongation is currently unclear. The present study aims to examine patterns of polysubstance use among a sample of Italian adults with BDZ dependence in relation with their QTc prolongation risk. We used Latent Class Analysis (LCA) on data collected from 251 inpatients of the Addiction Medicine Unit in Verona to group patients into three classes according to their substance use and their QTc prolongation risk. Results showed no significant relationship between QTc prolongation and BDZ use in any of the classes considered. We conclude that BDZs, even if used long-term and at high dosages, can be considered safe in terms of cardiovascular complications for patients.

Indexed as

Long QT SyndromeAdultBenzodiazepinesElectrocardiographyFemaleHumansLatent Class AnalysisRisk FactorsBenzodiazepines

Identifiers

PMID38168538
PMCPMC10762262
OpenAlexW4390508778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.